Members of the first Asian-Pacific Topic Conference: Dr Tomiyasu Arisawa, Dr Toshimi Chiba, Dr Shin Fukudo, Dr Shigeru Harasawa, Dr Ken Haruma, Dr Michio Hongo, Dr Akio Inui, Dr Hiroshi Kaneko, Dr Motoyasu Kusano, Dr Keiichi Matsueda, Dr Hiroto Miwa, Dr Koji Nakada, Dr Toshikatsu Okumura, Dr Choitsu Sakamoto, Dr Daisuke Sasaki, Dr Keiko Shiratori, Dr Hidekazu Suzuki, Dr Hiroshi Takeda, Dr Kazunari Tominaga, Dr Akira Torii, Dr Mamoru Watanabe, Dr Koji Yakabi, Dr Nicholas G. Burgess, Dr Yawen Chan, Dr Full-Young Chang, Dr Shengliang Chen, Dr Uday C. Ghoshal, Dr Xiao-Hua Hou, Dr Hye-Kyung Jung, Dr Udom Kachintorn, Dr Ching-Liang Lu, Dr Sanjiv Mahadeva, Dr Evan David Newnham, Dr Hyojin Park, Dr Choo Hean Poh, Dr Sanjeev Sachdeva, Dr Ratha-korn Vilaichone, Dr Justin Che-yuen Wu, Dr John Wyeth.
Diagnosis and treatment of functional gastrointestinal disorders in the Asia-Pacific region: A survey of current practices
Article first published online: 28 MAR 2011
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd
Journal of Gastroenterology and Hepatology
Special Issue: Proceedings of the first Asian Pacific Topic Conference (APTC2010) on Functional Gastrointestinal Disorders Organized by the Japanese Society of Gastroenterology (JSGE)and Asian Pacific Association of Gastroenterology (APAGE), Tokyo, Japan, 26-27 November 2010
Volume 26, Issue Supplement s3, pages 2–11, April 2011
How to Cite
Miura, S., Sugano, K., Kinoshita, Y., Fock, K. M., Goh, K. L., Gibson, P. and Members of the first Asian-Pacific Topic Conference organized by the Japanese Society of Gastroenterology and Asian Pacific Association of Gastroenterology (2011), Diagnosis and treatment of functional gastrointestinal disorders in the Asia-Pacific region: A survey of current practices. Journal of Gastroenterology and Hepatology, 26: 2–11. doi: 10.1111/j.1440-1746.2011.06635.x
Conflicts of interest: Kentaro Sugano declares that he received consulting fee from AstraZeneca plc, Takeda Pharmaceutical Co. Ltd, Dainippon Sumitomo Pharma Co. Ltd., research grants from Takeda Pharmaceutical Co. Ltd, Astellas Pharma Inc, Eisai Co Ltd, Otsuka Pharmaceutical Co., and lecture fee from Takeda Pharmaceutical Co. Ltd, Astellas Pharma Inc, and, Dainippon Sumitomo Pharma Co. Ltd. Other authors report no conflict of interest related to this study.
- Issue published online: 28 MAR 2011
- Article first published online: 28 MAR 2011
- Accepted for publication 24 January 2011.
- Asia-Pacific region;
- functional dyspepsia;
- irritable bowel syndrome;
Background and Aims: Functional gastrointestinal disorders (FGIDs), namely functional dyspepsia (FD) and irritable bowel syndrome (IBS) are common disorders important to public health in the Asia-Pacific region. Our objectives were to determine the current practices in diagnosis and management of these disorders in the Asia-Pacific region.
Methods: Forty-three physicians and researchers in FGID who attended the first Asian Pacific Topic Conference at Tokyo in November 2010 were invited to answer a questionnaire. Twenty-three Japanese doctors and twenty doctors from other Asia-Pacific Societies answered the questionnaire, which consisted of 60 multiple-choice questions concerning physician's preferences in diagnosis and management of FGIDs.
Results: Overall, there were similarities in diagnostic approach, such as differential diagnosis, exclusion of organic diseases, psychophysiological assessment, medical advice or medication with psychological drugs, not only among different Asia-Pacific region but also between FD and IBS. Several notable differences were seen. For example, general practitioners did not commonly use the term FD or diagnose FD by themselves, while the term IBS was widely used and frequently diagnosed. Sub-categorization was more common in IBS than FD. There was also a difference between Japan and other Asia-Pacific region; upper GI endoscopy and blood examination were more common in Japan, while eradication of Helicobacter pylori was more frequently done in other countries. Anti-secretory drugs for FD and mild laxatives or anti-diarrheal drug for IBS were frequently used, and prokinetics were used for all patients with FD or IBS. Interestingly, drugs developed in Japan and Chinese herbal medicines were more frequently prescribed in Japan.
Conclusion: Information obtained in this survey is useful for understanding the most common clinical approaches for FGIDs in the Asia-Pacific region.